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Abstract: Dextran aldehyde (dexOx), resulting from the periodate oxidative cleavage of 1,2-diol
moiety inside dextran, is a polymer that is very useful in many areas, including as a macromolecular
carrier for drug delivery and other biomedical applications. In particular, it has been widely used for
chemical engineering of enzymes, with the aim of designing better biocatalysts that possess improved
catalytic properties, making them more stable and/or active for different catalytic reactions. This
polymer possesses a very flexible hydrophilic structure, which becomes inert after chemical reduction;
therefore, dexOx comes to be highly versatile in a biocatalyst design. This paper presents an overview
of the multiple applications of dexOx in applied biocatalysis, e.g., to modulate the adsorption of
biomolecules on carrier surfaces in affinity chromatography and biosensors design, to serve as a
spacer arm between a ligand and the support in biomacromolecule immobilization procedures or
to generate artificial microenvironments around the enzyme molecules or to stabilize multimeric
enzymes by intersubunit crosslinking, among many other applications.
Keywords: dextran; dextran-aldehyde; enzyme immobilization; enzyme modification
1. Introduction
Enzymes are undoubtedly the most efficient catalysts ever known, as they can proficiently
perform their catalytic function under mild conditions, in a very specific (modifying only the target
physiological substrate) and selective (producing only the target product) manner [1–15]. As a result,
they are extremely useful in very diverse areas of application. However, the current features of
enzyme biocatalysts have been acquired after an extremely long-lasting natural evolution process,
thereby improving the physiological function of living organisms. On the other hand, some of these
features that are necessary for microorganisms to respond to changes in the environment do not
fit the requirements for large-scale industrial applications [16]. Nevertheless, enzymes have found
application in many industrial processes, from fine chemistry [1,12,13] to energy production [17–21] or
food technology [22–25]. When employed as industrial biocatalysts, the desired enzymatic capability
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may not be always the same; for instance, chemo- and regio-selectivity will be always necessary,
while enzyme stereoselectivity would be demanded in the resolution of racemic mixtures or in the
desymmetrization of prochiral compounds. Enzyme specificity also makes these biocatalysts very
suitable in analytical chemistry [26–29]. Thus, many enzymatic biosensors have been developed to
determine the concentration of one specific component inside a very complex mixture (e.g., glucose in
blood [30,31]). Another application of enzymes can be found in the field of medicine, where they can
be supplemented in order to supply some endogenous enzyme deficiencies or to degrade some target
deleterious compounds [32,33]. In this case, enzyme specificity and selectivity are both required, as
only the target compound must be degraded, without generating any toxic side-product. Conversely,
enzyme stability and activity are crucial parameters in most enzyme applications, as enzymes need
to remain active during storage, transport, and utilization [34–36]. Stability in a bioreactor involves
the resistance of the enzyme to alter its conformation under operation conditions, or against chemical
modification if some reactive substrates or by-products are present (e.g., hydrogen peroxide [37]).
For biosensors, the operational stability of the enzyme is crucial, since the signal should exist even in
the presence of inhibitors, inactivation reagents, etc. [36,38]. In some cases, the lack of any detected
signal is the “required signal”, as in those cases when the sensor must detect some agents that reduce
enzyme activity [39–42]. Thus, it is mandatory to differentiate whether the enzyme has been inactivated
by changes in the medium (e.g., drastic pH, or increase temperature) or it is really inhibited by the
target compound. On the other hand, if the detection of the compound is performed in situ, e.g., inside
a reactor, the enzyme must be resistant to the attack of any other enzyme or metabolite released by
the microorganism and changes in the conditions (pH, for example). Moreover, in biomedicine the
enzyme must be stable towards proteolysis and cell capture in other cells different from the target
tissue, but it must be able to simultaneously penetrate the target location [38].
Furthermore, enzyme solubility may be a problem in some applications. Clearly, this may not
be the case when using enzymes in biomedicine (although there are some circumstances where
its immobilization is also required, e.g., in extracorporeal dispositives [43–46]), but in most other
applications enzyme immobilization is required, mainly when the enzyme is going to be reused
(as happens in industrial biocatalysis). In these cases, it must be separated from the reaction media, or
it should be fixed on the tip of a transducer to maximize the signal (e.g., in biosensors) [47–56]. In fact,
enzymes, despite being extremely useful in many areas, in many instances need to be improved to
optimize their behavior under industrial operational conditions. Fortunately, there are many ways to
enhance enzyme capabilities; for instance, the development of metagenomics tools has permitted the
exploitation of all biodiversity, including non-cultivable microorganisms or even no longer existing
ones [57–60]. On the other hand, directed evolution allows for mimicking natural evolution by
specifically improving the target property of the desired enzyme [61–65]. Finally, chemical modification
and enzyme immobilization [66–70] are evolving in order to allow the development of more specific
and directed enzymatic modifications.
In this sense, dextran aldehyde (hereinafter referred as dexOx) has been used in many cases in
the design of improved biocatalysts [70,71]. DexOx is a multifunctional and random coil polymer,
commercialized with very different sizes [72], which has been widely used to modify free or immobilized
enzymes, to modify supports involved in enzyme manipulation with different objectives, or even as
spacer arm in enzyme immobilization. This review will focus on the different uses of this polymer in
the design of improved biocatalysts.
2. Dextran and Dextran Aldehyde (DexOx)
2.1. Dextran
Dextran is a polysaccharide formed by poly-α-D-glucosides of microbial origin having glycosidic
bonds predominantly C-1→C-6, as defined by the IUPAC [73] (Figure 1). This biopolymer, which is
naturally synthesized by many bacteria growing on sucrose-containing media [74], presents a great
Catalysts 2019, 9, 622 3 of 43
variety of lengths (ranging between 3 and 2000 kDa), and displays between 50 and 97% of α-1,6
linkages, and a small degree of branching (α-(1→2), α-(1→3) and/or α-(1→4) branching points).
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Dextran is produced by dextransucrases of Leuconostoc spp. [75,76], eissella spp. [77,78] and
lactobacilli [79,80]. Currently, most of the commercially available dextrans are obtained from
Leuconostoc mesenteroides [81,82]. Traditionally, the main use of low molecular weight fractions of
dextrans inside the biotechnology world has been as a plasma volume expander [83,84], not only
because of its linear structure and high water solubility, but also because its chemical composition
(mainly based on α-1,6 linkages). This fact makes dextrans less prone to suffer enzymatic hydrolysis
compared to other oligosaccharides based on α-1,4 linkages, such as glycogen [85], which may be
cleaved by microbial dextranases in the gastrointestinal tract.
The water solubility of dextrans varies depending on the branching degree: on the one hand,
those dextrans possessing around 95% of linear structure are fully soluble. On the other hand, as the
branching proportion increases, the solubility progressively decreases, and those dextrans possessing
ore than 43% of α-(1 3) are considered to be water insoluble [86]. In any case, the relatively high
water solubility of dextrans, as well as their high stability in both mild acidic and basic conditions and
its large amount of hydroxylic groups, make dextrans an excellent material for undertaking different
derivatization protocols or any kind of chemical or physical crosslinking [86,87]. Generally, the C-2
hydroxyl group is the most reactive, and the conjugation of different molecules to dextran can be
carried out following different procedures [86], as depicted in Figure 2. These different methodologies
possess a common feature: the glucopyranose ring of the polysaccharide remains unaltered. In any
case, the most common for of dextran-modification is probably the generation of aldehyde pendant
groups via periodate oxidation, which implies an opening of the heterocyclic ring: this point will be
discussed further in Sections 2.2 and 2.3.
Direct esterification (Figure 2a) is generally carried out by conjugation of hydroxyl groups of
dextran ith carboxylic acid via activation with N,N-dicyclohexylcarbodii ide (Cy-N=C= -Cy).
any ester prodrugs of dextran, such as most non-steroidal anti-inflammatory (NSAIDs) drugs,
have been synthesized through this methodology [88]. Another classical methodology allows
the attachment of molecules possessing amine or hydroxyl groups by creating carba ate (b ) or
carbonate (b ) ester linkages, follo ing a previous activation of all hydroxyl groups of dextrans using
phosgene [89]; some other procedures avoiding the use of toxic phosgene have been also described [90].
Similarly, the activation of dextrans with carbonyldiimidazole and ethylenediamine leads to dextran
derivatives possessing pendant amino groups (c), whereby succinimidyl-activated derivatives of other
hydroxyl-containing substances can be attached (c1). On the other hand, amine containing compounds
can be covalently linked to dextran by using the well-known cyanogen bromide activation (d), through
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which an isourea bond is formed (d1). Finally, irreversible etherification of dextrans can be carried out
using aliphatic or aromatic halides (e), epoxides (f) or conjugated carboxamides (g).
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Thus, by using any of the previously mentioned methods, dextrans have been applied as
macromolecular carriers for the delivery of drugs and proteins, aiming to increase the durability
of several therapeutic agents inside the systemic circulation [86,91–95]. In fact, molecules with
Mw < 40 kDa (half-life times of around 8 h) are easily eliminated via renal filtering, whereas upon
dextran-conjugation, the molecular weight of these prodrugs may be increased to values higher than
40 kDa, leading to increased half-lives. Consequently, these dextran-conjugated molecules would
be retained in the liver and spleen, and then they would be gradually released through endo and
exodextranase-catalyzed hydrolysis [96]. Moreover, dextrans have been also used for reducing the
in vivo immunogenicity of proteins and enzymes [97,98].
Aside from this use, dextran-based materials are very useful for other biomedical applications [99]
such as soft tissue reconstructions [100]. Additionally, iron-dextran derivatives can be used for treating
iron-deficiency anemia [101,102], while dextran-sulphate coatings enhance the biocompatibility
of inorganic systems [103]. Gene transfection is another biomedical area in which dextrans are
advantageous [94]; in fact, because of the high biodegradability of DNA and RNA, it becomes
mandatory to guarantee the safe delivery of gene vectors for providing successful gene therapies.
Therefore, and due to the fact that viral vectors, although possessing excellent transfection efficiency,
are also toxic and may lead to immunogenicity problems, the use of polycationic macromolecules is an
excellent alternative vehicle for nucleic acid drugs [104–106]. Inside this area, dextran derivatives have
been frequently used [107–110] because of their beneficial features, as recently reviewed by Huang
and Huang [93]. Finally, it is worth mentioning the use of dextran-hemoglobin conjugates as blood
substitutes for patients suffering from asthma or other hemoglobin-compromised conditions. These
dextran derivatives not only increase the therapeutic efficiency by enhancing the binding and release
of oxygen [111–114], but also prevent hemoglobin excretion (avoiding any kidney damage [115,116]),
reduce the non-renal clearance of hemoglobin (therefore minimizing risks of tissue edema [117]) and
reduce the auto-oxidation described for other hemoglobin-based oxygen carriers (reducing tissue and
cellular toxicity [118]).
2.2. Dextran Aldehyde (DexOx)
The use of the periodate anion for oxidative cleavage of dextrans was first reported by L. Malaprade
as early as 1928 [119]. Since then, this catalyst-free aqueous glycol (1,2-diol) cleavage has been known as
Malaprade oxidation [120], whose mechanism is assumed to involve an acidic cyclic ester intermediate
that decomposes to yield two carbonylic compounds, as shown in Figure 3.
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compared to the C2-C3 bond [125]; in any case, the aldehyde groups are not detected either with FTIR
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These transient structures may interfere with the overall oxidative pathway, so the final oxidation
degree can vary. Therefore, for mild oxidations (not generating formic acid), different colorimetric
titrations have been used, assuming in all cases that both aldehydes will equally react with the
titrating reagent. Nevertheless, Maia and coworkers [123], using a bidimensional NMR analysis of the
condensation products of dexOx with different N-nucleophiles (adipic acid dihydrazide, tert-butyl
carbazate or ethyl carbazate), confirmed that only one aldehyde per residue, the one at C3, was reacting
with the carbazates under mild acidic conditions, while the other one (mainly C4) is involved in the
formation of more stable hemiacetals. It has been observed that hemiacetals might exist in a very
narrow pH window, between 4.0 and 5.2; below that value, aldehydes are present, while for pH values
over 5.2, enols and enolate ions can be detected [126]. Interestingly, when the oxidation of dextran is
carried out in the presence of DMSO, the second oxidation is not detected, because the formation of
the hemiacetals is strongly promoted [127]. Hence, it can be inferred that the determination of the
oxidation degree of dextran is not a trivial question, and its control is crucial for the efficient design
of the intended modification methods [99]. For this purpose, the amount of aldehyde groups has
traditionally been determined by spectrophotometric (using carbazates [128,129] or dinitrosalicilic
acid [130]) or potentiometric [131] titration.
2.3. Coupling of Enzymes to DexOx
The usual methodology for coupling proteins and other biomolecules to dexOx is by reacting the
pendant aldehyde groups of dexOx with nucleophilic residues, mainly amine groups of lysine residues,
to create reversible imine (Schiff base [132]) linkages, at alkaline pH values (from 9 to 10) [133,134].
This condensation generates a water molecule per iminic bond formed (Figure 6), and in aqueous
media the equilibrium is shifted towards the hydrolysis of the C=N bond, returning to the starting
substrates (carbonyl and amine). However, there is some evidence suggesting that some cycles may be
involved in the reaction between amino groups and dexOx, making the coupled product more stable.
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3. Aplications of Dextran and DexOx in Biocatalysis
3.1. Glycosylation of Enzymes and Promotion of Intramolecular Crosslinkings
One of the applications of dexOx has been the artificial glycosylation of free or immobilized
enzymes. The large size of the dextran molecule will produce a large change in the physical and
chemical properties of the protein surface with a minimal chemical modification of the enzyme,
therefore allowing an alteration in many of the functional properties of the proteins.
Although dexOx is a random coil molecule with scarce rigidity, some authors tried to increase
the enzyme rigidity using intramolecular covalent crosslinking. For instance, soluble cellulase from
Aspergillus niger was modified using dexOx, with a significant improvement in enzyme stability versus
inactivation, both thermal or mediated by sodium dodecylsulfate [144]. In another example, dextran
sulfate was oxidized with periodate, and this polysaccharide was employed to modify an α-amylase
from Aspergillus oryzae, maintaining the enzymatic activity at a pH value lower than that the one for the
non-modified enzyme [145]. These same authors detailed the conjugation of horseradish peroxidase
with dexOx, also reporting an improved enzyme stability in thermal and pH inactivation [146].
Maksimenko et al. [147,148] disclosed a hyaluronidase that was modified with dexOx using a very
intense crosslinking (the amine modification degree was 96–100%), which was practically not inhibited
by heparin, in contrast to the behavior observed for the unmodified counterpart. Similarly, this
hyaluronidase-dexOx conjugate showed a higher activity in the presence of caotropic agents, allowing
us to enlarge the range of pH in which the enzyme was active; thus, heparin inhibition slightly differed
between pH 5.5 (1.5-fold inhibition) and 7.5 (1.2-fold inhibition), while the ionic strength of the reaction
medium only slightly influenced the enzymatic activity.
In some other classical examples, urease was modified using dexOx and its functional properties
were improved [149]. In another research, papaya proteinase was modified with dexOx- cysteine for
increasing the number of sulfhydryl groups in the enzyme environment, enabling an increase in the
activity of the composite [150]. The stabilization of dexOx-Cysteine-modified papaya proteinase was
explained by two reasons: firstly, the rigidification of the biocatalyst structure by the crosslinking
produced an increased stability; secondly, the enzyme was stabilized by the prevention of protein
association via thioldisulfide exchange reaction. In another research effort, glucoamylase from
Aspergillus niger was modified with dexOx, trying to get a high crosslinking degree that permitted
enhancing the enzyme stability [151]. In order to increase the dexOx crosslinking of the enzyme,
it was aminated (aminating both the sugar chains of the protein and the carboxylic residues of the
enzyme), promoting a further increase in enzyme stability and activity at high temperatures. Similarly,
superoxide dismutase modified with dexOx was more thermostable than the unmodified enzyme [152],
and this modified enzyme also exhibited a better antifibrous activity in experimental silicosis [153].
Sometimes, the dexOx modification is carried out on previously immobilized enzymes, with the
aim of stabilizing an area of the enzyme not involved in the immobilization. In a first example, the
lipase B from Candida antarctica was initially immobilized on octyl-agarose via interfacial activation,
and subsequently modified through amino terminal residue using dexOx [154]. This one-point
modification altered the secondary structure of the enzyme, modifying its functional properties,
making the modified enzymes more stable, active, and selective toward different substrates than
the unmodified lipase B from Candida antarctica. In another paper [155], lipases from Thermomyces
lanuginosus and Rhizomucor miehei and lipase B from Candida antarctica, immobilized via interfacial
activation on octyl agarose [156,157], were aminated using the carbodiimide route [158,159]. Then,
they were submitted to an intense crosslinking with dexOx, reporting a large increase (ranging from 4
up to 250-fold, depending on the enzyme) on the stability for these immobilized lipases (Figure 7).
This was attributed to the formation of an intense intramolecular covalent crosslinking [155].
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Enzymes become inactivated when they interact with hydrophobic interfaces [160], such as gas
bubbles [161,162] or organic solvents [163–166]. It is well known that by immobilizing them in porous
supports, this inactivation can be prevented [167], while soluble enzymes may be readily inactivated
by these very undesirable interactions. Thus, it has been proposed that the coating of the enzyme
molecules with large polymers may solve this limitation, as the hydrophobic interface cannot reach
the protein core due to the shell formed by the polymer. This has been exemplified using ionic
polymers [168–170], which will coat the surface via ionic interactions, or dexOx, which will cover the
surface of the enzymes via covalent bonds. Thus D-amino acid oxidase, glucose oxidase and trypsin
were coated with dexOx, reporting and increase in stability of the immobilized enzymes in the presence
of hydrophobic interfaces [171]. In another paper, cellulase from Aspergillus niger modified with dexOx
was described to be more stable in the presence of air bubbles (residual activity of about 50% for
4 h) [144]; correspondingly, horseradish peroxidase modified with dexOx was not only more stable
and active than the free enzyme in presence of an organic-aqueous interface, but also became less
prone to suffer inhibition in the presence of heavy metal salts and various denaturing compounds [172].
This stabilization versus interaction with hydrophobic interfaces was later extrapolated to the enzymes
immobilized on nonporous nanoparticles (Figure 8). Glucose oxidase immobilized by multiple covalent
attachments in non-porous nanoparticles was inactivated by interaction with hydrophobic interfaces
(e.g., gas bubbles) [173], because the immobilized enzyme remains exposed to the external interfaces.
This inactivation does not occur when the enzyme was immobilized (even by a single point) in
porous supports. However, the coating of the enzymes with dexOx when immobilized on non-porous
nanoparticles enabled us to overcome this inactivation problem [173] (Figure 8).
A dexOx molecule can carry many molecules to be used in the modification of a protein. Taking
advantage of the multifunctionality and large size of dexOx, it has been utilized to introduce a high
number of the target molecules (attached to the dextran) while promoting a scarce chemical modification
of the protein. For example, this has been used to raise antibodies versus small molecules, as small
molecules are unable to raise an immunogenic answer. When antibodies for these molecules are
required, they must be attached to large molecules, usually proteins like keyhole limpet hemocyanin and
these antigen-modified protein molecules are injected in the host mammal [174–177]. Keyhole limpet
hemocyanin protein coated with dexOx may be used as a protein carrier to promote immunoresponse
versus low-size antigens, enabling us to modify this protein using many aminated antigens. These
molecules were used to raise high concentrations of antibodies versus the aminated antigens [178].
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In other cases, as the size of dexOx is larger than that of the enzyme, several different enzyme
molecules can be immobilized in one dextran molecule. For example, many molecules of horseradish
peroxidase and biotin were attached to large dexOx molecules to build a macromolecule probe [179].
In another example, some molecules of ovomucoid proteinase inhibitor from duck egg white were
attached to dexOx [180]. While the number of inhibitor molecules attached to the dextran does not
have any effect on the inhibitory activity of the composite, a strong negative effect on this capacity
depending on the number of dextran-ovomucoid bonds was observed [180]. Moreover, when few
ovomucoid molecules are attached to dexOx, the protein-protein interactions are minimal, as the
polymeric chain prevents the formation of protein aggregates.
3.2. Dextran Aldehyde in the Preparation of Cro slinked Enzyme Aggregates (CLEAS)
Prof. Sheldon proposed in 2000 a new enzyme immobilization protocol without the use of any
carrier, the crosslinked enzyme aggregates (CLEAs) [181]. This strategy is based on the aggregation
of the enzyme molecules intended to be immobilized by adding some precipitant reagents, and a
subsequent chemical crosslinking used to create water-insoluble aggregates; so, these aggregates become
physically stable and cannot be re-dissolved when the precipitant reagent is washed away [182–184].
The strategy has many advantages compared to the crosslinked enzyme crystals (CLECs), regarding
the purity requirements (maximum purity for CLECs, no requirement for CLEAs), possibility of
coimmobilizing enzymes or enzymes and polymers, etc. [167,182,185]. While finding conditions where
an enzyme solution may precipitate maintaining high levels of activity are fairly easy, the crosslinking
step is the bottleneck of the CLEAs preparation in many instances. The crosslinking mechanism
generally involves reactive primary amino groups of the protein (epsilon-amino group of Lys residues
and N terminus); some proteins may not possess a high amount of this residue on the surface, so that
in these cases, the CLEA preparation is not straightforward. This has been solved by using a feeder
(which can be a Lys-rich protein [186–193] or an aminated polymer [194,195]), by a chemical amination
of the enzy e [196–198] or by using an alternative crosslinking group in the enzyme (e.g., carboxylic
groups) [199]. Usually, the crosslinking reagent is glutaraldehyde [182,184] due to its good properties
as crosslinking reagent [200,201]. On the other hand, some researchers have shown that dexOx can
alternatively be used in the crosslinking step due to its large size and the high number of aldehyde
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groups. In this way, the lipase from Burkholderia cepacia was immobilized using CLEA technology
using both glutaraldehyde and dexOx as a crosslinker [202]. The use of aldehyde dextran allowed for
obtaining lipase derivatives with a higher activity, although with a lower stability, very likely due to
the higher flexibility of dextrans.
Anyhow, the use of glutaraldehyde as crosslinker agent is not suitable when any Lys residue is
critical for enzyme activity/stability, as glutaraldehyde can reach those amino groups hidden in pockets
in the enzyme. In this case, the large size of dexOx may be a smart solution so as to avoid the undesired
modification of critical groups located in enzyme pockets.
Thus, CLEAs of hydroxynitrile lyase, alcohol dehydrogenase, penicillin G acylase and different
nitrilases from two different sources were prepared using dexOx as a crosslinking reagent and the results
were compared to those obtained using glutaraldehyde [203]. In most instances, higher immobilization
yields were obtained using this multifunctional polymer when compared with glutaraldehyde. This
dexOx crosslinking reduced the losses in functional active sites; for instance, CLEAs of formate
dehydrogenase from Candida boidinii (very useful for NADH regeneration and CO2 reduction) were
produced using dexOx, reporting a higher activity and stability compared to that obtained with
glutaraldehyde [204].
A general problem associated with CLEAs is the existence of strong substrate diffusional limitations,
mainly if the enzyme activity is very high or when using large substrates. In this sense, another
positive effect of using dexOx instead of glutaraldehyde is the generation of larger pores, therefore
reducing these substrate diffusional problems [205–208]. For instance, CLEAs of β-mannanase were
prepared using dexOx; scanning electron microscopy confirmed the porous structure with low steric
hindrances, leading to a 16-fold increase of the enzymatic activity when compared to the CLEA
crosslinked with glutaraldehyde [209]. In another paper, CLEAs of α-amylase were obtained using
many different polysaccharides (agar, chitosan, dextran, and gum arabic) previously oxidated with
periodate as croslinkers. The best results were those obtained using ammonium sulphate as precipitant
agent and cross-linked by using dexOx, doubling the activity obtained using glutaraldehyde; CLEA
stability was also higher when using dexOx [210]. Similarly, α-amylase from Aspergillus oryzae and
glucoamylase from Aspergillus niger were used to produce CLEAs, and once again the crosslinking with
dexOx furnished an enzymatic derivative of the α-amylase more active (3-fold) than that prepared
with glutaraldehyde [211]. However, no activity recovery was observed for the glucoamylase, due
to the enzyme affinity for dextran. Finally, β-glycosidase from bovine liver was utilized to produce
CLEAs that reportrfthe highest recovered activity when using dexOx [212].
Some papers show other alternatives to the use of dexOx as a crosslinker agent. Thus,
several complexes of Ru(II)-diimine (with 4,4′- or 5,5′-dicarbaldehyde-2,2′-bipyridine and
5′-carbaldehyde-1,10-phenanthroline) were used to crosslink cytochrome P450 BM3 variants showing
peroxygenase activity, reporting improved results when compared to those achieved with dexOx or
glutaraldehyde [213]. This higher stabilization was attributed to the presence of a modular number of
aldehyde groups and a rigid framework of the new crosslinker, leading to a better rigidification of the
enzyme structures compared to glutaraldehyde or dexOx.
3.3. Dextran Aldehyde for Controlling the Adsorption of Biomacromolecules on Support Surfaces
The modification of some supports with dexOx can greatly increase their biocompatibility and
hydrophilicity. It has been described that the modification of silicon surfaces with dexOx (using
different sizes and oxidation degrees) reduces the adsorption of proteins on the support surface, being
the oxidation percentage of the dextran the key parameter [214]. This modification confers antifouling
properties on the new materials.
Additionally, dextrans are extremely flexible and, after reduction to convert their aldehyde groups
into hydroxyl groups, they become hydrophilic and inert macromolecules. Thus, their application as
surface coatings can prevent the multipoint interaction of biomacromolecules with the support surface,
while their random coil nature still permits the one-point interaction. This has a great relevance in
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affinity chromatography, where a strong one-point interaction with the target protein (rather than any
multipoint interaction of other proteins leading to unspecific adsorption) is highly desirable [215–217].
In this sense, one of the most successful reports is the design of Immobilized Metal Chelate Affinity
(IMAC) columns to specifically adsorb proteins with one poly-His tag, while not adsorbing any native
proteins. The poly-His tagged protein can become immobilized via a double interaction between two
His groups in the tail and one chelate in the support, while the native proteins need to involve several
His residues for the immobilization interacting with several chelate groups in the support [218–223].
Therefore, using a lowly activated support, the poly-His tagged enzyme is largely the only one which
will get immobilized, while native proteins will not be adsorbed [224]. Unfortunately, this means
a very low adsorption rate. A rational proposal to overcome this drawback is to coat the IMAC
support with dexOx in order to avoid the multipoint adsorption while the one point adsorption
capacity of the support remains almost intact [225] (Figure 9). By using this methodology, the measured
immobilization rate was around 80% compared to the adsorption rate for the naked supports, while
the specificity was similar to that obtained, with supports having a 10-fold lower superficial density
than the IMAC groups, enabling the (almost) fully selective adsorption of the target enzyme. The
blocking design was critical; a double modification using dextrans with different sizes was required to
get optimal results [225].
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Another problem commonly presented when using highly activated supports for enzyme
purification, is the extremely high adsorption strength between large proteins (that is, possessing many
groups able to interact with the support) and activated supports. In this scenario, the ulterior release of
the enzyme may be too difficult due to the establishment of a very intense multipoint protein-support
interaction, even if an initial selective adsorption via the poly His tag has been achieved. This
complication has been also solved using this dexOx coated supports [225]. Considering that most
enzyme adsorptions on support surfaces are based on multipoint interactions, their prevention by
similar techniques can have a very positive effect on the specificity of the biomacromolecules adsorption
processes on a support [226].
In another example, an ion exchanger capable of adsorbing only small proteins was prepared. This
was achieved by initially coating the support with a moderately large protein (bovine serum albumin),
so that the only available space for adsorbing another protein molecules was the one placed between
bovine serum albumin molecules [227]. However, the first results were quite disappointing, as most
proteins from milk whey became adsorbed, as a consequence of the direct interaction of these proteins
with the immobilized bovine serum albumin molecules. This conclusion was derived by comparing
the previous system with the one using a support of just bovine serum albumin immobilized on an
inert surface (glyoxyl-agarose) [227,228]. Thus, the immobilized bovine serum albumin was coated
with dexOx, and it was observed that their adsorption capacity was suppressed. The same strategy
using an ion exchanger support permitted us to have a fully selective matrix for small proteins [227],
so that small beta-lactoglobulins and alpha-lactalbumin from dairy whey were specifically adsorbed,
while other larger proteins contained in the whey (IgGs, for example) remained in the supernatant
(Figure 10).
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nother useful application for the control of unspecific adsorption of bio acro olecules on the
support surface is in the field of biosensors. In this case, an ideal biosensor should exclusively adsorb
the target olecule, hile leaving other bio acro olecules in the supernatant (including reading
antibodies, for exa ple) [229].
I obilization of antibodies on a inated supports is a very popular ethod to produce
i unosensors. Follo ing this ethodology, the i obilization using the oxidized sugar chains of
antibodies as spacer ar s keeps al ost full recognition capacity of the i obilized i unoglobulin,
regardless of the size of the antigen [230]. However, this strategy presents some disadvantages; first of
all, this cationic support may lead to a non-specifically protein adsorption via anion exchange [230–235].
In fact, this support was able to adsorb not only the desired antibody but also many proteins presented
in the sample, including the reading antibody (Figure 11). The direct blocking with dexOx was not
efficient enough; actually, it prevents unspecific adsorption on the support surface but at the same
ti e it produced a decrease in the recognition capacity of the antibody, because the terminal a ino
groups of the antibodies are near to the recognition area (Figure 12). However, by using aspartic
acid-dexOx, the formation of a “smart coating” is achieved, as this reagent is mainly directed towards
the support aminated surface while hardly modifying the antibody, and is capable of eliminating the
unspecific proteins adsorption while maintaining more than 80% of the initial recognition capacity of
the immobilized antibody [236] (Figure 13).
The second problem observed using aminated supports and the sugar chains as spacer arms in the
antibody immobilization was the drastic drop of the biosensor activity under storage conditions, even
at 4 ◦C [236]. Despite this, it remained possible to recover the initial immunoactivity by incubating the
biosensor in a high concentration of buffering solutions, suggesting that this problem was derived
from the collapse of the antibody on the support aminated surface (the sugar chain is a long and
flexible spacer arm which cannot prevent that from occurring). The coating of the support with aspartic
acid-dexOx also prevented this undesired effect [236] (Figure 14).
Catalysts 2019, 9, 622 14 of 43
Catalysts 2019, 9, x FOR PEER REVIEW 14 of 42 
 
 
Figure 11. Antibodies immobilized on aminated supports: good functionality by many proteins can 
become unspecifically adsorbed on the support. 
 
Figure 12. Antibodies immobilized on aminated supports coated with dexOx the unspecific 
adsorption of proteins in the support is prevented, but the function of the antibody is also eliminated. 
i r . ti i i ili i t rt : f cti ality r t i
c s cific ll s r t s rt.
Catalysts 2019, 9, x FOR PEER REVIEW 14 of 42 
 
 
Figure 11. Antibodies immobilized on aminated supports: good functionality by many proteins can 
become unspecifically adsorbed on the support. 
 
Figure 12. Antibodies immobilized on aminated supports coated with dexOx the unspecific 
adsorption of proteins in the support is prevented, but the function of the antibody is also eliminated. 
Figure 12. Antibodies immobilized on aminated supports coated with dexOx the unspecific adsorption
of proteins in the support is prevented, but the function of the antibody is also eliminated.
In another example, both dexOx and aspartic acid-dexOx were used to immobilize aminated
DNA probes on aminated supports [237]. This time, aspartic acid-dexOx was simultaneously the
spacer arm where the aminated DNA probes were immobilized (via the aldehyde groups) and the
blocking reagent (the dextran chains promoting steric hindrances and the aspartic groups enabling
the partial blocking of the amino groups in the support surface). The naked aminated support was
able to unspecifically adsorb DNA fragments of any length. This was avoided using the coating
with the aspartic-dextran [237]. On the other hand, the fast detection of G group Streptococcus and
Staphylococcus aureus was described based on the affinity chromatography involving the interaction of
proteins A and G of the bacterial cell wall with the Fc fragment of human IgG [238]. Similarly, the
modification with dexOx reduced nonspecific adsorptions and interaction problems.
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Not always the modification of a support surface with dexOx produces a more inert surface: It
is necessary to make the modification in a proper way. In fact, the adsorption capacity of a support
may even increase if the support modification with dexOx is not properly designed. For instance,
dextran modification of polydimethylsiloxane particles increased the adsorption of fibrinogen and
albumin even though the contact angle of the support surface was reduced from 109◦ to 80◦(showing
the support surface hydrophilization) [239].
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3.4. Dextran Aldehyde as Active Group and Spacer Arm in the Support
In some instances, DexOx has been used as an alternative active group for different supports
in some instances, because their aldehyde groups can react with amine groups of the proteins and
supports. In this sense, lipase from Candida rugosa was immobilized on a macroporous resin using
dexOx as active group, and the biocatalyst was used to produce oleyl oleate via esterification in a
solvent-free system [240]. The best results were obtained using 20 KD dexOx as spacer arm. In another
paper, the use of dexOx as spacer arm was applied to an electrospray production of immobilized protein
microarrays (on aluminized plastic), leading to a highly advantageous devices showing the highest
sensitivity and the lowest noise [241]. These positive results are caused by the mobility of the molecules
attached to the dextran and also by a reduction on the adsorption of other non-desired proteins via
multipoint interactions with the support. Similarly, trypsin immobilization on hydrophobic polyester
fleece FO 2413 via dexOx and bovine albumin reported the highest proteolytic activity compared
to other spacer arms [242]; the authors explained the results attending to the decrease of the steric
hindrance and some environmental effects promoted by the immobilization surface. Thus, bovine
serum albumin was useful fordecreasing negative effects of the hydrophobic support, but as a rigid
polymer, the enzyme molecules immobilized on it did not have mobility. The use of dextran as spacer
arm conferred more mobility on the immobilized molecule. This increased the recovered activity, but
it also allowed the interaction of the immobilized trypsin molecules with the hydrophobic surface if
the coating was not adequate [242]. In another stimulating research study, a comparison was drawn
between two ways of using dexOx for enzyme immobilization. Hence, a β-glucosidase was coated with
dexOx and later this composite was immobilized on aminopropyl silica; alternatively, aminopropyl
silica was modified with dexOx and later β-glucosidase was immobilized on this support [243]. The
highest stabilization was achieved when the enzyme was initially modified with dexOx, maybe because
this strategy permitted the stabilization of the multimeric structure of the enzyme, or as stated by
the authors, because this protocol made the 100% of the enzyme surface available for the enzymatic
immobilization [243].
However, in other instances, the use of dexOx as spacer arm and reactive group takes advantage
of other specific features of dextran. One of the highest advantages of using dexOx as the spacer
arm is related to its structure (random coil polymer), which confers a high mobility to any molecule
attached to it, provided that the dextran is attached to the support surface by just a few bonds and to
the enzyme by, ideally, just one linkage (Figure 15). Moreover, dextran is very hydrophilic and mainly
inert after reduction with sodium borohydride, avoiding any undesired enzyme-spacer arm interaction
after immobilization. For large-sized substrates, if short spacer arms are used, only those enzyme
molecules properly oriented will remain active, while for dexOx-immobilized protein molecules, most
of them will be capable of converting the substrate (Figure 15). In this sense, dexOx was used to
activate a silicate carrier which was subsequently employed to attach lysozyme, maintaining some
activity even in the lysis of a substrate as large as a bacterial cell wall [244]. On the other hand, free
β-amylase was modified with dexOx, reporting an activity decrease as a result of steric hindrances in
the vicinity of the catalytic site (show by an inverse correlation between substrate size and activity
recovery [245]). Then, the dexOx modified enzyme was immobilized on amino activated silica,
maintaining a much higher activity compared to that obtained when the enzyme was immobilized on
glutaraldehyde-activated supports. This was explained by the increased mobility of the enzyme when
immobilized using dexOx; moreover, the modified enzyme was more stable than the free enzyme
or the glutaraldehyde-immobilized derivative [245]. Similarly, a protease from Streptomyces 771 was
immobilized on dexOx-activated supports, exhibiting reasonable activity recoveries compared to the
use of rigid and short spacer arms [246]. In another described example, agarose beads activated with
lowly activated dexOx were employed to immobilize rennin (for hydrolyzing casein) and protein
A (that must interact with immunoglobulins) [247]. Proteolytic activity of immobilized rennin was
reported to be 15-fold higher than the activity of rennin immobilized on an aldehyde support bearing
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shorter spacer arms, while the new immobilized protein A preparations adsorbed, as expected, 2 IgG
molecules per immobilized protein A molecule [247].
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In other cases, the multifunctionality of dextrans is the desired property. For instance, it has
enabled us to build molecules like dexOx-aspartic, and to use this polymer as a spacer arm for
immobilizing aminated DNA probes. Thus, it was possible to immobilize many aminated DNA probes,
keeping an almost full mobility of the probe, at the same time avoiding the unspecific adsorption
of DNA fragments (see Section 3.3), so that promoting a remarkable increase in the response rate
and detection limit becomes possible (one complementary DNA molecule per milliliter of problem
sample [237]).
The high size of dextran is also beneficial in some cases. In fact, many enzyme molecules can
be immobilized on one dextran molecule, therefore increasing the loading capacity of a support.
For example, 2000 KDa dexOx was used to immobilize multiple copies of alkaline phosphatase, around
27–31 molecules of enzyme were attached per dextran molecule [248]. Afterward, these composites
were immobilized in a nylon membrane, reporting a 14–20 fold increase in the chemiluminescence
signal when compared to the same amount of enzyme directly adsorbed on a nylon membrane. This
biocatalyst was utilized for the high-throughput chemiluminescence detection of biotin-conjugated
anti-rabbit antibody, finding a detection limit of 880 attomol per spot on the nylon membrane [248].
3.5. Generation of Hydrophilic Microenvironments in Immobilized Enzymes
The modification of immobilized enzymes with dexOx has been proposed as a useful tool to
generate a hydrophilic shell surrounding the enzyme molecules. This hydrophilic shell can induce
the partition of hydrophobic molecules away from the enzyme environment [34], thus reducing the
cause of enzyme inactivation, that is, the concentration of solvent in contact with it, leading to enzyme
stabilization in the presence of hydrophobic organic cosolvents.
The first attempt to follow this strategy was described using penicillin G acylase immobilized
on glyoxyl agarose [249–251]. The coating of the immobilized enzyme with dexOx produced some
disappointing results, because no stabilization was observed after enzyme coating; in fact, stability
was even lower in the presence of organic solvents after dexOx enzyme coating [251]. Similarly,
coimmobilization of the enzyme with polyethylenimine did not show any positive effect regarding the
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stability of the immobilized penicillin G acylase in organic solvents [251], even though this polymer
had been frequently reported to be useful for this purpose [252]. The authors explained these results
considering that the enzyme coating with the hydrophilic polymers was not perfect, so that some
areas of the protein remained exposed to the organic solvent [251]. Finally, the combination of
polyethylenimine coimmobilization with penicillin G acylase on the glyoxyl-agarose support and
the further coating with dexOx led to the generation of a highly hydrophilic nano-environment fully
surrounding the immobilized enzyme molecules. This biocatalyst retained 80% of the activity of the
free enzyme and was stabilized 1000-times when incubated in 90% tetraglyme [251]. The stabilization
effect was subsequently enhanced by adding successive layers of the polymers and including sulfate
dextran to increase the “saline” effect of the modification [253,254]. These biocatalysts, displaying this
“hyperstabilization” effect versus the deleterious influence of organic solvents, could be efficiently used
in several applications, such as the hydrolysis of penicillin G in the presence of methyl isobutyl ketone
(used to extract penicillin G from the fermentation medium) without a significant decrease in enzyme
activity/stability [255], the production of amides using a thermodynamically-controlled synthesis in
media containing a high percentage of cosolvent [256], or the resolution of racemic phenylacetamides
in the above-mentioned media [257].
Similarly, β-galactosidases from different sources (Kluyveromyces lactis, Escherichia coli and
Aspergillus oryzae) were immobilized on glutaraldehyde-agarose and then modified by reaction
with dexOx and finally with polyamine-dextran [258]. This strategy produced a significant stabilization
of all immobilized enzymes in organic solvents, while scarcely affecting the kinetic parameters of the
immobilized enzymes. These data suggested that the hydrophilic shell appears to behave as an open
structure (that permits the entry of the substrates) and produces a “solvent partition effect” that protects
the immobilized enzymes from interaction with the hydrophobic organic, as shown in Figure 16.Catalysts 2019, 9, x FOR PEER REVIEW 19 of 42 
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Sometimes, modified dextran has been used to generate a hydrophobic pocket surrounding
on the enzyme environment, which enables a protection versus hydrophilic agents like hydrogen
peroxide [37]. So, modification of D-amino acid oxidase from Rhodotorula gracilis immobilized on
glyoxyl-agarose with dexOx bearing hydrophobic groups enabled us to increase the enzyme stability
compared to hydrogen peroxide [259].
3.6. Stabilization of Multimeric Enzymes
The prevention of the dissociation of multimeric enzymes is very relevant for the stability
of this type of enzymes, as in some instances the first step of the inactivation is the subunit
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dissociation [71,260–262], as depicted in Figure 17. This disaggregation will make enzyme stability
dependent on enzyme concentration, and would also hamper the use of these biocatalysts in a
continuous reactor, as the continuous washing will remove the released enzyme subunits [71].
Moreover, even if the enzyme subunit dissociation is not the first cause for enzyme inactivation, when
using an immobilized enzyme, if the subunits become released from the support (even after enzyme
inactivation), they will contaminate the reaction medium [71] (Figure 18).Catalysts 2019, 9, x FOR PEER REVIEW 20 of 42 
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target in biocatalysts design, which has been addressed by many different approaches: molecular
genetics (to reinforce the enzyme assembly by improving the ionic network [263,264] or by
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disulfide formation [265,266]), immobilization [267,268] or chemical modification [269,270]. Although
polyethylenimine (PEI) has been used in some instances to stabilize multimeric enzymes [169,252], the
reversible nature of this modification has promoted the use of dexOx as a good alternative. However, in
some cases the dexOx chemical modification produces detrimental effects on the enzyme activity and
the only alternative is the use of PEI [168]. In any case, the reasons for preferring these multifunctional
and large molecules to small bifunctional ones, even leading to a lower rigidification degree, are very
evident [69,70]:
• The polymer size and the presence of multiple reactive groups make the one-point chemical
modification less probable than the desired crosslinking.
• Similarly, also caused by the number and size of reactive groups, it is not necessary that the
distance between the chemical groups involved in the crosslinking must fit one specific size.
• The flexibility of dextran allows one single molecule of dextran to react with a large percentage of
the enzyme surface.
Remarkably, the inter-subunit crosslinking of multimeric enzymes had been mainly described
using immobilized enzymes [71]. This has some advantages; first, as the enzyme is already stabilized,
it is more likely that the ulterior chemical modification would cause a smaller effect on the enzyme
activity. Secondly, this modification is clearly easier taking advantage of the simplicity associated to
solid phase chemistry. Finally, as some of the enzyme subunits will be already attached to the support
and stabilized by immobilization, it is only required to attach the non-immobilized enzyme subunits
to some of the immobilized ones to prevent enzyme dissociation. Accordingly, by the end of last
century, it was clearly shown that the treatment with dexOx of an immobilized crude protein extract
permitted the full intermolecular crosslinking of virtually every multimeric enzyme immobilized in an
agarose support [271]. Later, the strategy was individualized for specific cases; thus, the tetrameric
L-asparaginase from Escherichia coli was immobilized on glutaraldehyde-agarose, observing improved
enzyme stability. However, some subunits could be released from the support because they were not
actually attached to the support. This was solved by the treatment of the immobilized enzyme with
dexOx and opened new scenarios for using this asparaginase preparation [272]. In another research
study, the tetrameric α-amino acid ester hydrolase from Acetobacter turbidans was immobilized on
glyoxyl agarose, but still one enzyme subunit remained unattached to the support [273]. This fact
limited the viable reaction conditions for its use as catalysts in the kinetically controlled synthesis of
ampicillin. Nevertheless, the treatment of the immobilized biocatalysts with dexOx endorsed the use
of this biocatalysts in 40% methanol and with low concentrations of phosphate ions (anion otherwise
needed to stabilize the multimeric structure of the enzyme), so that the final ampicillin yield could be
greatly improved (over 90%) [273].
Catalases are multimeric enzymes frequently used coupled to oxidases in order to reduce
the negative impact of the released hydrogen peroxide [37], so that many examples in which the
catalase subunits have been crosslinked to improve the biocatalyst stability may be found in literature.
For example, Mn-catalase from Thermus thermophilus strains HB8 and HB27 were stabilized by
immobilization on glyoxyl agarose [274]. However, a direct correlation between enzyme concentration
and stability was still observed, pointing towards the dissociation of some enzyme subunits, so
that the modification with partially oxidized dextrans permitted the stabilization of the quaternary
structure of these enzymes [274] (Figure 18). Conversely, tetrameric bovine liver catalase was
immobilized on glyoxyl agarose, once again enhancing the enzyme stability, but not involving all
enzyme subunits. This was solved by dexOx intersubunit crosslinking, as catalase immobilized either
on lowly activated supports (where just one subunit was immobilized) or on highly activated supports,
(where 2–3 subunits were involved in the immobilization) [275]. In another example, multimeric
catalase from Aspergillus niger was covalently immobilized on agarose, increasing the enzyme stability
even though some subunits were still not immobilized [276]. The further coating with dexOx avoided
this problem, although enzyme concentration/stability dependence was still detected. This permitted
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to find that Zn2+ was also critical for enzyme stability. That way, the stabilization of the multimeric
enzyme structure enabled to discover another dissociative process related to the inactivation of this
enzyme [276].
Xylanase,β-xylosidase andα-L-arabinofuranosidase from Penicillium janczewskii were immobilized
on glyoxyl agarose, and after crosslinking with partially oxidized dexOx, the enzymes stabilities were
greatly increased [277]. This strategy originated a combibiocatalyst able to fully hydrolyze wheat
arabinoxylans and oat spelt, with xylose yield higher than 40%. Another reported paper described the
immobilization of glycerol dehydrogenases from Geobacillus stearothermophilus, Citrobacter braakii and
Cellulomonas sp. on different agarose beads, being the results using amine and glyoxyl support the best
ones [278]; once again, a further treatment with dexOx stabilized the multimeric structure of the enzyme,
also decreasing the inhibition of the enzyme caused by the reaction product (1,3-dihydroxyacetone).
Multimeric deoxyribonucleoside kinase from Drosophila melanogaster was immobilized via anionic
exchange in an aminated support and after intersubunit cross-linking with dexOx maintained was more
than 30% of the activity [279]. This stabilized biocatalyst was employed for the preparative production
of fludarabine monophosphate and arabinosyladenine monophosphate. In another example, the
multimeric alcohol oxidases from Hansenula sp, and Pichia pastoris were immobilized on glyoxyl
agarose [280]. The stability of the enzymes improved, but still some enzyme subunits were not
immobilized on the support, as a consequence some subunit dissociation was found. The problem
could be solved by treatment with dexOx, although in this case a serious decrease of enzyme activity
was reported.
Thermophilic enzymes are fascinating enzymes, by far more stable than their mesophilic
counterparts [281–288]. A reported mechanism of enzyme thermostabilization in these organisms
is the production of multimeric enzymes, that increase their global stability. However, also for
thermophilic enzymes the subunit dissociation during biocatalysts operation is a problem [68]. That
way, prevention of enzyme subunit dissociation as cause of enzyme inactivation or after the enzyme
has been inactivated remains as a goal in the design of immobilized biocatalysts involving thermophilic
enzymes. For example, a hexameric alpha-galactosidase from Thermus sp. T2 was immobilized on
cyanogen bromide-activated agarose (via a single-point linkage), obtaining a biocatalyst displaying a
stability similar to that of the free enzyme. This strategy was unable to avoid the release of enzyme
subunits from the biocatalyst [289]. The further intersubunit cross-linking with dexOx of these
biocatalysts increased the enzyme stability and prevented the enzyme subunit release. Moreover, a
thermostable β-galactosidase from Thermus sp. strain T2 was immobilized on heterofunctional epoxy
supports [290]. The enzyme immobilized on Sepabeads-epoxy-boronic was found to be the most stable,
but still one enzyme subunit was not-attached to the support; this was solved by dexOx coating of the
biocatalyst, avoiding any enzyme subunit release (Figure 18), although reducing the enzyme stability,
because the inactivation of this enzyme is not initialized by the subunit dissociation and the polymer
was less rigid than the enzyme.
Occasionally, PEI and dexOx have been compared to check their ability to stabilize oligomeric
enzymes, in some cases reporting the best results by using just one of them, while in other instances the
combination of both polymers produced the highest biocatalyst stabilization. For example, this is the
case of a hexameric glutamate dehydrogenase from Escherichia coli, an enzyme whose stability presented
a very significant dependence on the protein concentration [168]. In this particular case, the crosslinking
with dexOx caused the enzyme inactivation, leaving the treatment with polyethylenimine as the only
way to stabilize the quaternary structure of the enzyme. In another example, the tetramericβ-xylosidase
from Selenomonas ruminantium was immobilized on glyoxyl agarose beads, with scarce effect on enzyme
stability due to the possibility of subunit release [291]. It was treated with polyethylenimine or
dexOx. The PEI treatment produced the most stable enzyme preparation. In another example, the
homotetrameric sucrose synthase from Acidithiobacillus was immobilized-stabilized on differently
activated agarose beads, leading to the highest stability when using glyoxyl agarose [292]. However,
as some subunits were not attached to the support, the biocatalyst was treated with dexOx or/and
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polyethyleneimine, observing that the combined use of both polymers fully stabilized the quaternary
structure of the enzyme.
In other instances, the enzyme was adsorbed on PEI-coated supports. For example, pectinase was
immobilized on polyethyleneimine-coated acrylate copolymer DILBEAD-VWR and hereinafter used
for clarification of apple juice [293]. In this particular case, only the treatment with dexOx permitted the
stabilization of the enzyme, allowing the reuse of the support after enzyme inactivation by washing with
1 N HCl to eliminate from the inactivated biocatalyst every molecule of inactivated enzyme. In another
example, multimeric nucleoside 2′-deoxyribosyltransferase from Bacillus psychrosaccharolyticus CECT
4074 was immobilized onto several supports, being the best results those obtained by adsorbing the
enzyme on PEI-agarose [294]. Further crosslinking with dexOx avoided subunit dissociation and greatly
improved the enzyme function. Conversely, recombinant multimeric uridine and purine nucleoside
phosphorylases from Bacillus subtilis were immobilized onto polyethyleneimine Sepabeads [295].
As these preparations showed a dependence of their stability on the enzyme concentration, they were
crosslinked with dexOx. This treatment avoided the risk of enzyme dissociation (Figure 18) and
permitted that the biocatalysts were successfully utilized in the production of 2′-deoxyguanosine via an
enzymatic transglycosylation in an aqueous solution between 2′-deoxyuridine and guanine [295,296].
3.7. Enzyme Coimmobilization Using DexOx as Glue
Enzyme coimmobilization presents some kinetic advantages in a cascade process [297–300].
However, it also involves some drawbacks, such as the decrease in the relative loading capacity of
the support for each enzyme, the dependence of the overall stability of the whole biocatalyst on
the particular stability of the less stable component of this combined catalyst, and the need to use
the same immobilization technique for all enzymes [167]. Therefore, some new coimmobilization
strategies are being studied [301–304]; one of the solutions proposed for the first above-mentioned
problem involves the use of dexOx (Figure 19.) In fact, dexOx was used to coimmobilize tetrameric
β-D-galactosidase from Kluyveromyces lactis [305,306] and the lipase from Thermomyces lanuginosus
previously immobilized on hydrophobic magnetic nanoparticles [307]; after lipase immobilization,
the enzyme was chemically aminated and thereafter, the lactase was coimmobilized via ion exchange
on the aminated enzyme. A final treatment of the coimmobilized enzymes with dexOx, promoting
the intermolecular crosslinking, avoided any lactase release [307] and increased the stability of the
galactosidase, very likely due to the crosslinking of the monomeric subunits [71].
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3.8. -Use of dexOx for Intermolecular Crosslinking of Immobilized Enzyme Molecules
Physical adsorption of proteins on activated supports is a very useful and simple method to
immobilize enzymes [167,235]; however, as the surfaces will never be physically inert [167], this
could be deleterious for the stability of the immobilized enzyme [308], as new enzyme-support
interactions may be produced during storage or operation, leading to enzyme inactivation [309,310].
Furthermore, each individual enzyme-support linkage is too weak to increase the enzyme rigidity [167].
In fact, only multimeric enzymes should be stabilized upon immobilization on these supports,
provided that all enzyme subunits are involved in the immobilization, preventing the subunit
dissociation [71]. Nevertheless, there is a particular situation where enzymes become stabilized
upon physical immobilization: the immobilization of lipases on hydrophobic supports via interfacial
activation, allowing the immobilization, stabilization, purification and hyperactivation of the lipases
in just one step [157]. Anyhow, the inherent drawback of this immobilization protocol is caused by
the enzyme release from the carrier to the medium, under certain conditions and in the presence of
detergent-like molecules [311], reducing the range of reaction conditions where these biocatalysts may
be used (Figure 20). This has been solved using different heterofunctional supports, bearing different
groups on the support surface with different functions for a better control of the immobilization
procedure [312–315], performing the physical intermolecular crosslinking of the immobilized enzyme
using polyethylenimine [316–318] or using dexOx as chemical crosslinking reagent [319] (Figure 21). The
large size and number of functional groups of dexOx allow multi-intermolecular enzyme crosslinking,
thus preventing enzyme release.
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l ri r ti .
In a representative example, the hydrolysis of fish oils by the lipase from Rhizomucor miehei
immobilized on hydrophobic supports and crosslinked with dexOx could be performed in a reaction
medium containing high concentrations (50%) of a water-miscible organic solvent (2-propanol);
under these conditions, the hydrolysis increased the biocatalyst selectivity towards the release of
eicosapentaenoic acid versus docosahexaenoic acid (from 4:1 to 22:1) [319]. In another paper, the lipase
from Candida cylindracea immobilized on hydrophobic supports was treated with dexOx and dextran
sulphate and used to generate a biocatalyst able to hydrolyze fish oil in a biphasic system formed
by 50% of 1/4 oil/hexane and 50% of polyethylene glycol/phosphate buffer (4/6) [320]. In this case,
both stability and activity were higher using dextran sulphate, this could be because of the higher
hydrophilicity of the enzymatic shell.
Another fully different use of dexOx is in the area of proteomics. It has been shown that a rapid
crosslinking of a protein solution (e.g., using a high concentration of dexOx) rapidly coats the proteins
surfaces and avoids any crosslinking between two non-associated protein molecules [321]. On the other
hand, it has been shown that only large proteins will become adsorbed on lowly aminated supports,
as ion exchange requires a multi-interaction between the enzyme and the support [322] (Figure 22).
Having these two concepts in mind, a strategy was developed in order to get associated enzymes, even
when the percentage of oligomeric proteins was minimal, based on the selective adsorption of the
protein complexes on tailor-made anionic exchanger supports (to shift the association equilibrium
to the oligomeric form) and a further crosslinking with aldehyde dextran (to stabilize the complex
and, consequently, to make possible the release of the complex from the support in an associated
form) [226,323] (Figure 23).
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Later, the same group were able to produce protein aggregates of the desired size using bovine
serum albumin, a protein with a great tendency to aggregate [324–327]; just decreasing the activation of
the support, it was possible to get larger aggregates, being the dexOx crosslinking essential to maintain
these aggregates after their release from the support [328] (Figure 24).
Catalysts 2019, 9, 622 26 of 43
Catalysts 2019, 9, x FOR PEER REVIEW 26 of 42 
 
 
Figure 23. Shifting association equilibrium of weak enzyme complexes using lowly activated supports 
and final crosslinking of the immobilized complexes with dexOx. 
 
Figure 24. Controlling the aggregation of BSA by controlling the activation of ion exchangers and final 
crosslink of the BSA complexes with dexOx. 
4. Conclusions 
As shown throughout this article, dexOx is a very useful reactive polysaccharide within the field 
of biocatalysis. Its easy use, as well as the multiple applications that it presents, make dexOx an 
extremely valuable biomolecule to solve some critical situations in biosensor and biocatalysts design, 
including not only enzyme immobilization but also purification. The key for its applicability is the 
mobility and inertness (after chemical reduction) inherent to dexOx, while this flexibility helps the 
enzyme stabilization via rigidification complex. Thus, its application in the design of matrices for 
affinity chromatography and production of biosensors is based on these features. The huge amount 
of reactive groups inside dexOx and its large size make it very convenient for stabilization of 
i r . tr lli t e re ti f c tr lli t e cti ti f i e c ers fi l
crossli k of t e S co lexes ith dex x.
4. Conclusions
As shown throughout this article, dexOx is a very useful reactive polysaccharide within the field of
biocatalysis. Its easy use, as well as the multiple applications that it presents, make dexOx an extremely
valuable biomolecule to solve some critical situations in biosensor and biocatalysts design, including
not only enzyme immobilization but also purification. The key for its applicability is the mobility
and inertness (after chemical reduction) inherent to dexOx, while this flexibility helps the enzyme
stabilization via rigidification complex. Thus, its application in the design of matrices for affinity
chromatography and production of biosensors is based on these features. The huge amount of reactive
groups inside dexOx and its large size make it very convenient for stabilization of multimeric enzymes
via subunit crosslinking, while also making it ideal as a spacer arm for enzymes acting over large
substrates. Multiple examples of very useful applications will surely be published in the coming years,
exploiting some of these features. It has been our purpose to summarize some of these applications
for many different enzymes and proteins (antibodies, hydrolases, oxidoreductases, etc.) in order to
provide a comprehensive compilation of dexOx expediency in the chemical engineering of biocatalysts.
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